Related Experiment Video
Updated: Feb 8, 2026

Modeling Chemotherapy Resistant Leukemia In Vitro
Published on: February 9, 2016
The bitter side of epigenetics: variability and resistance to chemotherapy
Nabil Hajji1, Daniel J García-Domínguez2, Lourdes Hontecillas-Prieto2
1The John Fulcher Molecular Neuro-Oncology Laboratory, Division of Brain Sciences, Imperial College London, London, UK.
Abstract:
One of the major obstacles to the development of effective new cancer treatments and the main factor for the increasing number of clinical trial failures appears to be the paucity of accurate, reproducible and robust drug resistance testing methods. Most research assessing the resistance of cancers to chemotherapy has concentrated on genetic-based molecular mechanisms, while the role of epigenetics in drug resistance has been generally overlooked. This is rather surprising given that an increasing body of evidence pointing to the fact that epigenetic mechanism alterations appear to play a pivotal role in cancer initiation, progression and development of chemoresistance. This resulted in a series of clinical trials involving epi-drug as single treatment or combined with cancer conventional drugs. In this review, we provided the main mechanisms by which the epigenetic regulators control the resistance to cancer drugs.
Insights
Accurate drug resistance testing is crucial for cancer treatment development. This review highlights the overlooked role of epigenetics in chemotherapy resistance and its therapeutic potential.
Area of Science:
- Oncology
- Molecular Biology
- Pharmacology
Background:
- Drug resistance is a major cause of cancer treatment failure.
- Current research primarily focuses on genetic mechanisms of chemoresistance, neglecting epigenetic factors.
- Epigenetic alterations are increasingly recognized for their role in cancer development and drug resistance.
Purpose of the Study:
- To review the primary mechanisms of epigenetic regulation in cancer drug resistance.
- To highlight the significance of epigenetics in overcoming treatment failures.
- To inform the development of novel epigenetic therapies for cancer.
Main Methods:
- Literature review of studies on epigenetics and cancer drug resistance.
- Analysis of epigenetic mechanisms influencing chemoresistance.
- Synthesis of findings from clinical trials involving epigenetic drugs.
Main Results:
- Epigenetic modifications significantly impact cancer cell response to chemotherapy.
- Epigenetic regulators control key pathways involved in drug resistance.
- Clinical trials show promise for epigenetic drugs in cancer treatment.
Conclusions:
- Epigenetics plays a critical role in chemoresistance, offering new therapeutic avenues.
- Understanding epigenetic mechanisms is essential for improving cancer treatment efficacy.
- Targeting epigenetic regulators presents a viable strategy to combat drug resistance in cancer.
Related Concept Videos
Epigenetic Regulation
Epigenetic Regulation
X-chromosome...
Variability: Analysis
The range is a simple measure of variability, indicating the difference between the highest and...
Random Variables
Uppercase letters such as X or Y denote a random variable. Lowercase letters like x or y denote the value of a random variable. If X is a random variable, then X is written in words, and x is given as a number.
For example, let X = the...
Graphs of Equations in Two Variables
Variables Affecting Phosphorescence and Fluorescence

